Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 3, Issue 12
1 December 2004
Issue Cover
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

Antisense oligonucleotides targeted to the human α folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment
Mona S. Jhaveri; Antonina S. Rait; Koong-Nah Chung; Jane B. Trepel; Esther H. Chang
View articletitled, Antisense oligonucleotides targeted to the human α folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment
Open the PDF for in another window
The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH2-terminal kinase–dependent mechanism
Xin-Yan Pei; Yun Dai; Steven Grant
View articletitled, The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH<sub>2</sub>-terminal kinase–dependent mechanism
Open the PDF for in another window
Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin
Alexandre I. Belenkov; George Shenouda; Ekatarina Rizhevskaya; Denis Cournoyer; Jean-Philippe Belzile; Luis Souhami; Slobodan Devic; Terry Y.K. Chow
View articletitled, Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin
Open the PDF for in another window
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity
James Turkson; Shumin Zhang; Jay Palmer; Heidi Kay; Joseph Stanko; Linda B. Mora; Said Sebti; Hua Yu; Richard Jove
View articletitled, Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity
Open the PDF for in another window
Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells
Im-Sook Song; Niramol Savaraj; Zahid H. Siddik; Peiman Liu; Yingjie Wei; Chun Jing Wu; Macus Tien Kuo
View articletitled, Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells
Open the PDF for in another window
Different proteome pattern of epidermal growth factor receptor–positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment
Sergej Skvortsov; Bettina Sarg; Judith Loeffler-Ragg; Ira Skvortsova; Herbert Lindner; Helmut Werner Ott; Peter Lukas; Karl Illmensee; Heinz Zwierzina
View articletitled, Different proteome pattern of epidermal growth factor receptor–positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment
Open the PDF for in another window
A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy
Rhona Stein; David M. Goldenberg
View articletitled, A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy
Open the PDF for in another window
In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles
Chee Onn Leong; Marie Suggitt; David J. Swaine; Michael C. Bibby; Malcolm F.G. Stevens; Tracey D. Bradshaw
View articletitled, <em>In vitro</em>, <em>in vivo</em>, and <em>in silico</em> analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles
Open the PDF for in another window
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference
P.L. Rachel Ee; Xiaolong He; Douglas D. Ross; William T. Beck
View articletitled, Modulation of breast cancer resistance protein (<em>BCRP</em>/<em>ABCG2</em>) gene expression using RNA interference
Open the PDF for in another window
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer
Minna Tanner; Anita I. Kapanen; Teemu Junttila; Olayinka Raheem; Seija Grenman; Jussi Elo; Klaus Elenius; Jorma Isola
View articletitled, Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer
Open the PDF for in another window
Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin
David J. Burkhart; Brian T. Kalet; Michael P. Coleman; Glen C. Post; Tad H. Koch
View articletitled, Doxorubicin-formaldehyde conjugates targeting α<sub>v</sub>β<sub>3</sub> integrin
Open the PDF for in another window
Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin
David J. VanderWeele; Rixin Zhou; Charles M. Rudin
View articletitled, Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin
Open the PDF for in another window
Epidermal growth factor receptor–related peptide inhibits growth of PC-3 prostate cancer cells
Dorota J. Marciniak; Arun K. Rishi; Fazlul H. Sarkar; Adhip P.N. Majumdar
View articletitled, Epidermal growth factor receptor–related peptide inhibits growth of PC-3 prostate cancer cells
Open the PDF for in another window
Highly efficient delivery of p16 antitumor peptide into aggressive leukemia/lymphoma cells using a novel transporter system
Eisaku Kondo; Masao Seto; Kazuhiro Yoshikawa; Tadashi Yoshino
View articletitled, Highly efficient delivery of p16 antitumor peptide into aggressive leukemia/lymphoma cells using a novel transporter system
Open the PDF for in another window
The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samples
Federica Di Nicolantonio; Louise A. Knight; Pauline A. Whitehouse; Stuart J. Mercer; Sanjay Sharma; Peter A. Charlton; David Norris; Ian A. Cree
View articletitled, The <em>ex vivo</em> characterization of XR5944 (MLN944) against a panel of human clinical tumor samples
Open the PDF for in another window
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth
Kazuhide Nakamura; Atsushi Yamamoto; Masaru Kamishohara; Kazumi Takahashi; Eri Taguchi; Toru Miura; Kazuo Kubo; Masabumi Shibuya; Toshiyuki Isoe
View articletitled, KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth
Open the PDF for in another window
Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor–related apoptosis-inducing ligand–induced apoptosis in melanoma cells
Susan K. Gillespie; Xu Dong Zhang; Peter Hersey
View articletitled, Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor–related apoptosis-inducing ligand–induced apoptosis in melanoma cells
Open the PDF for in another window
Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor–related apoptosis-inducing ligand–mediated cell death
Stephane Bergeron; Myriam Beauchemin; Richard Bertrand
View articletitled, Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor–related apoptosis-inducing ligand–mediated cell death
Open the PDF for in another window
Growth inhibitory effects of celecoxib in human umbilical vein endothelial cells are mediated through G1 arrest via multiple signaling mechanisms
Ho-Pi Lin; Samuel K. Kulp; Ping-Hui Tseng; Ya-Ting Yang; Chi-Cheng Yang; Chang-Shi Chen; Ching-Shih Chen
View articletitled, Growth inhibitory effects of celecoxib in human umbilical vein endothelial cells are mediated through G<sub>1</sub> arrest via multiple signaling mechanisms
Open the PDF for in another window
Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor–induced hepatotoxicity is mediated by Kupffer cells
Marlena M. Westcott; Ralph J. Abi-Habib; Kimberley A. Cohen; Mark C. Willingham; Shihui Liu; Thomas H. Bugge; Stephen H. Leppla; Arthur E. Frankel
View articletitled, Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor–induced hepatotoxicity is mediated by Kupffer cells
Open the PDF for in another window
Enhanced efficacy of therapy with antisense BCL-2 oligonucleotides plus anti-CD20 monoclonal antibody in scid mouse/human lymphoma xenografts
Mitchell R. Smith; Fang Jin; Indira Joshi
View articletitled, Enhanced efficacy of therapy with antisense BCL-2 oligonucleotides plus anti-CD20 monoclonal antibody in <em>scid</em> mouse/human lymphoma xenografts
Open the PDF for in another window

Commentary

Confirmation and prevention of targeted toxicity by a recombinant fusion toxin
Robert J. Kreitman
View articletitled, Confirmation and prevention of targeted toxicity by a recombinant fusion toxin
Open the PDF for in another window

Correction

Article on anti-STAT3 and prostate cancer
View articletitled, Article on anti-STAT3 and prostate cancer
Open the PDF for in another window

Advertisement

Breaking
Treatment with Low-Energy Electric Fields Ups Pancreatic Cancer Survival
Trump Taps Jay Bhattacharya to Lead NIH
Roche Snaps Up Poseida Therapeutics
View more recent articles
Latest News
French Liquid Biopsy Program Delivering Personalized Care
Hope and Hurdles for Menin Inhibitors in Leukemia
Aneuploid Cells in Normal Breast Tissue Challenge Cancer Paradigms
View more recent articles
Research Watch
Specialized Fibroblasts Shape T-Cell Environments in Lung Cancer
GD2-CAR T-cell Therapy is Safe in H3K27M+ Diffuse Midline Glioma
Characterization of Extrachromosomal DNA During Cancer Progression
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept